9107 Wilshire Blvd., Suite 450.

Beverly Hills, California 90210, USA


+1 (310) 984-6595

Cancer International Journal

About the Journal

Cancer is the one of the deadliest clinical manifestation that caused most mortality rate in the recent times. There is immense research is going on to find diagnostic methods, treatment options and drug development strategies. Boffin Access understands the need of an open access journal to disseminate current developments in cancer research and initiated an international open access journal "Cancer International Journal".

Aims and Scope

Cancer International Journal (CIJ) focuses on fields related to cancer that include various types of cancer such as breast cancer, prostate cancer, lung cancer, melanoma, etc and also integrates cellular and molecular biology with cancer progression. The journal mainly emphasizes on areas relevant to the cellular and molecular biology of cancer metastasis and tumor progression.

Cancer International Journal (CIJ) has international expert editorial board and review team and follows standard double blind review process and making editorial decisions based on the scientific merit. Authors can submit original reports, expert reviews, opinions, policy articles, communications, editorials and letters for publication.

Cancer International Journal (CIJ) publishes quality content and paves a platform to the clinicians, medical experts, academicians, industrial researchers, and policy makers to share and update the current knowledge.

Subjects covered by the Cancer International Journal

  • Molecular and cellular pathobiology
  • Prevention and cancer epidemiology
  • Tumor and stem cell biology
  • Cancer therapeutics and targets
  • Microenvironment and immunology
  • Molecular alterations or biomarkers that predict response
  • Progression of the malignant phenotype
  • Large-scale molecular characterization of human tumors
  • Single and combined drug administration modalities
  • Carcinogenesis
  • Tumor immunology and virology
  • Oncogenomics, proteomics and metabolomics
  • Molecular targeted agents and immune therapies
  • Autologous stem cell transplant
  • Cancer vaccine
  • Electrofulguration
  • Hereditary prostate cancer genes
  • Invasive lobular carcinoma
  • Waldenstrom macroglobulinemia
  • Wiskott-Aldrich syndrome
  • Chronic myelogenous leukemia
  • In situ non-invasive cancer
  • Intestinal cancer symptoms
  • Metastatic ovarian cancer
  • Oat cell cancer symptoms
  • Pituitary gland cancer
  • Squamous cell carcinoma
  • Advanced metastatic breast cancer
  • Philadelphia chromosome-positive chronic myelogenous leukemia
  • Osteosarcoma
  • Intestinal cancer symptoms
  • Hairy cell leukemia symptoms
  • Acute granulocytic leukemia
  • Burkitt's lymphoma
  • Cancer Statistics
  • Wilms' Tumour